Revolutionising Sepsis Diagnostics
Our patented, unique Enzymatic Template Generation and Amplification (ETGA®) technology offers a highly efficient method of detecting viable organisms (bacteria and fungi) in the bloodstream.
When ETGA® is combined with our innovative, universal microbial cell and circulating free DNA capture methods, we can provide a highly sensitive, actionable Gram categorisation: Gram positive and/or Gram negative and yeast discrimination in under 3 hours.
For more information please contact us by completing this form.
ABOUT MOMENTUM BIOSCIENCE
Driven by a global crisis
Our team at Momentum Bioscience are creating innovative approaches that enable healthcare professionals to act faster and smarter when confronted with patients suspected of sepsis. This will have a significant impact on the management of antibiotics and help mitigate the problem of increasing antibiotic resistance.
INVEST IN US
Opportunities still available
Momentum Bioscience is backed by venture and angel funding and currently engaged in a financing round to fund clinical trials of a less than 3-hour, direct from blood Gram test.
If you’d like more information on how to invest in us and be a part of the global call to action against antimicrobial resistance, then please complete the form opposite or email us.
If you'd like more information about investment opportunities please contact us by completing this form.
Research & Development
Momentum Bioscience Ltd
10 Blenheim Office Park
Oxon OX29 8LN
TEL: +44 (0)29 2167 7910